Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Alpha1-Antitrypsin Deficiency Significantly Increases Risk for Lung Cancer
Link ID 6103
Title Alpha1-Antitrypsin Deficiency Significantly Increases Risk for Lung Cancer
Url http://www.medscape.com/viewarticle/575125?src=rss
Description Carriers of the alpha1-antitrypsin deficiency might have a risk of developing lung cancer that is up to 70% higher than that for noncarriers of the genetic defect. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date May 28, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Exemestane May Improve Survival After Tamoxifen Therapy
  In women with early-stage, hormone receptor-positive breast cancer, extended therapy with the steroidal aromatase inhibitor exemestane after 5 years of treatment with tamoxifen significantly improves relapse-free survival, according to an analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 trial. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. Mutation in JAK2 Associated with ALL in Children with Down Syndrome
  Mutations in the JAK2 gene appear to be associated with nearly 20% of cases of acute lymphoblastic leukemia in children with Down syndrome. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
  The safety and efficacy of sorafenib is examined in patients 70-years and older with advanced renal cell carcinoma.
Journal of the National Cancer Institute
Category:   Articles > Hematology-Oncology


4. Hormone Therapy Compromises Mammograms and Breast Biopsies
  Women who use combined hormone therapy, even for short periods of time, are at significantly higher risk of having abnormal mammograms and undergoing breast biopsies. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Refining First-line Treatment for Metastatic Breast Cancer
  How do the experts take tumor biology, efficacy and safety data, and patient preferences into account to optimize treatment for metastatic breast cancer? Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS